A detailed history of Silvercrest Asset Management Group LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 41,523 shares of TMO stock, worth $21.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
41,523
Previous 41,512 0.03%
Holding current value
$21.4 Million
Previous $23 Million 11.88%
% of portfolio
0.18%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $5,850 - $6,866
11 Added 0.03%
41,523 $25.7 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $22.5 Million - $24.9 Million
-41,512 Reduced 50.0%
41,512 $23 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $20.2 Million - $22.4 Million
37,394 Added 81.95%
83,024 $45.9 Million
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $556,847 - $631,199
1,053 Added 2.36%
45,630 $26.5 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $413,290 - $510,556
958 Added 2.2%
44,577 $23.7 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $52,818 - $60,887
106 Added 0.24%
43,619 $22.1 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $729,640 - $848,271
1,435 Added 3.41%
43,513 $22.7 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $69,015 - $78,021
-129 Reduced 0.31%
42,078 $24.3 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $222,966 - $262,830
460 Added 1.1%
42,207 $23.2 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $525,448 - $626,251
-1,036 Reduced 2.42%
41,747 $21.2 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $1.11 Million - $1.36 Million
-2,224 Reduced 4.94%
42,783 $23.2 Million
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $346,888 - $426,937
662 Added 1.49%
45,007 $26.6 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $654,919 - $767,993
-1,151 Reduced 2.53%
44,345 $29.6 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $157,954 - $189,031
-310 Reduced 0.68%
45,496 $26 Million
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $125,244 - $144,340
-284 Reduced 0.62%
45,806 $23.1 Million
Q1 2021

May 17, 2021

BUY
$439.85 - $518.83 $4.12 Million - $4.86 Million
9,358 Added 25.48%
46,090 $21 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $500,319 - $606,809
-1,150 Reduced 3.04%
36,732 $17.1 Million
Q3 2020

Nov 16, 2020

SELL
$359.77 - $441.52 $126,639 - $155,415
-352 Reduced 0.92%
37,882 $16.7 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $365,190 - $480,825
1,327 Added 3.6%
38,234 $13.9 Million
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $45,954 - $61,209
-180 Reduced 0.49%
36,907 $10.5 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $57,921 - $69,872
-213 Reduced 0.57%
37,087 $12 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $100,171 - $114,968
389 Added 1.05%
37,300 $11 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $117,330 - $151,367
-553 Reduced 1.48%
36,911 $10.1 Million
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $40,443 - $48,884
-194 Reduced 0.52%
37,464 $8.38 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $11,511 - $13,681
-56 Reduced 0.15%
37,658 $9.19 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $140,572 - $151,914
692 Added 1.87%
37,714 $7.81 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $18,719 - $21,738
-97 Reduced 0.26%
37,022 $7.64 Million
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $269,768 - $296,948
1,482 Added 4.16%
37,119 $7.05 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $6.12 Million - $6.92 Million
35,637
35,637 $6.74 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.